中基健康(000972) - 2020 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2020 was ¥2,758,230.08, a decrease of 96.99% compared to ¥91,484,302.22 in the same period last year[8] - The net profit attributable to shareholders was -¥13,041,004.34, representing a 45.43% increase in losses compared to -¥8,966,936.17 in the previous year[8] - The net profit decreased by 44.47% to -¥13,053,465.20 from -¥9,035,125.01, reflecting reduced income and increased expenses[15] - The net loss for Q1 2020 was CNY 13,053,465.20, compared to a net loss of CNY 9,035,125.01 in Q1 2019, reflecting an increase in losses of approximately 44%[35] - The total comprehensive income for the parent company in Q1 2020 was -¥13,041,004.34, compared to -¥8,966,936.17 in Q1 2019, indicating a significant decline in overall performance[36] - Basic and diluted earnings per share for Q1 2020 were both -¥0.0169, worsening from -¥0.0116 in Q1 2019[36] Cash Flow and Liquidity - The net cash flow from operating activities was -¥4,790,684.39, which is a 63.16% improvement from -¥13,002,306.18 in the same period last year[8] - Cash and cash equivalents decreased by 66.27% to ¥27,197,614.66 from ¥80,644,820.58 due to loan repayments[15] - Cash received from sales dropped by 99.98% to ¥4,000.00 from ¥21,623,066.04, indicating no product sales during the quarter[15] - The company's cash and cash equivalents dropped from CNY 68,436,735.75 at the end of 2019 to CNY 14,980,430.44 by March 31, 2020, a decrease of about 78%[30] - The company reported a total cash outflow from financing activities of -¥48,005,077.36 in Q1 2020, compared to -¥16,172,991.27 in the same period last year, indicating increased cash outflows related to financing[44] - The cash received from other operating activities was 20,175.53 yuan, a notable increase from the previous period[45] Assets and Liabilities - The total assets at the end of the reporting period were ¥674,451,770.44, down 8.89% from ¥740,282,440.65 at the end of the previous year[8] - The total liabilities decreased from CNY 292,346,652.15 at the end of 2019 to CNY 239,569,447.14 by March 31, 2020, a reduction of about 18%[30] - The total equity attributable to shareholders decreased from CNY 441,936,607.51 at the end of 2019 to CNY 428,895,603.17 by March 31, 2020, a decline of approximately 3%[30] Operating Costs and Expenses - Operating costs decreased by 96.18% to ¥3,347,191.68 from ¥87,733,345.57, also due to factory shutdowns[15] - Management expenses increased by 35.12% to ¥11,382,896.18 from ¥8,424,348.49 due to costs associated with the shutdown[15] - The company incurred sales expenses of ¥20,832.67 in Q1 2020, up from ¥2,220.00 in Q1 2019, indicating increased costs associated with sales efforts[38] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 36,804[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 16.18% of the shares[10] Other Information - The company reported no non-recurring gains or losses during the reporting period[8] - The company did not undergo an audit for the first quarter report[48] - The company has not applied new revenue and leasing standards for the current reporting period[48]